Alcohol Use Disorder (AUD)

Understanding Alcohol Use Disorder

What AUD Is

AUD is a problematic pattern of alcohol use leading to clinically significant impairment or distress, as defined by the DSM-5. It exists on a continuum — from mild AUD (two or three criteria met) to severe AUD (six or more) — and replaces the older binary categories of abuse and dependence with a single dimensional diagnosis.

What AUD Is Not

AUD is not the same as drinking. It is not defined by a specific quantity or by the type of beverage. Two people can drink similar amounts and one meet criteria for severe AUD while the other does not, depending on the pattern of use, the consequences, and the loss of control. AUD is also not defined by daily drinking — some people with severe AUD binge episodically rather than continuously.

The Disease Model and Its Limits

AUD has clear neurobiological features — alterations in reward, motivation, and stress regulation — that justify a medical framework. At the same time, AUD is shaped by psychology, social context, trauma, and culture in ways that pure biological models cannot capture. The most useful framing is biopsychosocial: AUD is a real medical condition with measurable brain changes, occurring in human lives where meaning, relationships, and choice still matter.

Who Develops AUD

AUD occurs across every demographic. Risk is elevated in those with family history, early age of first use, trauma, untreated psychiatric conditions, and certain occupational and social environments where heavy drinking is normalized. No demographic is exempt, and stereotypes about what AUD "looks like" are one of the main reasons people delay seeking help.

DSM-5 Diagnostic Criteria

AUD requires meeting 2 or more of the following 11 criteria within a 12-month period:

Impaired Control

1. Alcohol taken in larger amounts or over a longer period than intended
2. Persistent desire or unsuccessful efforts to cut down or control use
3. Great deal of time spent obtaining, using, or recovering from alcohol
4. Craving — a strong desire or urge to use alcohol

Social Impairment

5. Recurrent use resulting in failure to fulfill major role obligations
6. Continued use despite persistent social or interpersonal problems caused or exacerbated by alcohol
7. Important activities given up or reduced because of use

Risky Use

8. Recurrent use in situations that are physically hazardous (driving, machinery)
9. Continued use despite knowledge of a persistent physical or psychological problem likely caused or worsened by alcohol

Pharmacological

10. Tolerance — need for increased amounts to achieve effect, or diminished effect with same amount
11. Withdrawal — characteristic withdrawal syndrome, or alcohol used to relieve or avoid withdrawal

Severity

• Mild: 2–3 criteria met
• Moderate: 4–5 criteria met
• Severe: 6 or more criteria met

Course Specifiers

• In early remission: No criteria (except craving) met for at least 3 months but less than 12 months
• In sustained remission: No criteria (except craving) met for 12 months or more
• In a controlled environment: Access to alcohol is restricted

Severity, Patterns, and Phenotypes

Mild AUD

Often invisible to others. Drinking has begun to cause consequences — failed attempts to cut back, conflict with a partner about drinking, occasional missed work — but functioning is largely intact. This is the stage where intervention has the best prognosis and the least cost.

Moderate AUD

Consequences are visible. Tolerance has typically developed. Work, relationships, and health are affected. Many people in this range still believe they can stop on their own, and many can with structured help.

Severe AUD

Daily life is shaped around drinking. Withdrawal symptoms appear if alcohol is not consumed. Medical, occupational, and relational consequences are substantial. Severe AUD typically requires medical management of withdrawal and a combination of medication and behavioral treatment.

High-Functioning AUD

People with high-functioning AUD maintain external markers of success — career, marriage, parenting — while meeting criteria for the disorder. This phenotype is overrepresented in professional and high-income populations and often delays treatment for years because the disorder is hidden by performance.

Binge Pattern vs. Daily Pattern

Some people with AUD drink heavily in episodes separated by periods of abstinence or moderate use. Others drink daily. Both patterns can meet criteria; both can produce severe consequences. Pattern matters for medical management — daily drinkers face more significant withdrawal risk on stopping.

Intoxication and Withdrawal

Acute Intoxication

Alcohol intoxication progresses through predictable stages: reduced inhibition and impaired judgment at lower blood alcohol levels, motor incoordination and slurred speech at higher levels, blackouts and loss of consciousness at high levels, and respiratory depression at potentially fatal levels. Alcohol poisoning is a medical emergency.

The Withdrawal Spectrum

In people with physiological dependence, stopping or reducing alcohol triggers a withdrawal syndrome that can range from mild to life-threatening.

Mild Withdrawal

Beginning 6–12 hours after the last drink: tremor, anxiety, irritability, insomnia, mild nausea, sweating, and elevated heart rate.

Alcoholic Hallucinosis

12–24 hours: visual, auditory, or tactile hallucinations while consciousness remains intact. Frightening but not necessarily life-threatening if managed.

Withdrawal Seizures

24–48 hours: generalized tonic-clonic seizures, sometimes multiple. Medical management with benzodiazepines reduces risk.

Delirium Tremens (DTs)

48–96 hours: severe confusion, autonomic instability, fever, agitation, and hallucinations. Mortality without treatment is approximately 15% and can occur even with appropriate care. DTs are a medical emergency requiring hospital management.

Medically Supervised Withdrawal

Detoxification with benzodiazepines (chlordiazepoxide, diazepam, lorazepam) is the standard of care for moderate-to-severe withdrawal. Thiamine should be given to prevent Wernicke-Korsakoff syndrome. Outpatient detox may be appropriate for low-risk patients with good support; higher-risk withdrawal requires inpatient management.

Detox Is Not Treatment

Detoxification addresses the acute withdrawal — but it does not treat AUD. Without follow-up with medication and behavioral therapy, relapse is the norm. Detox should be planned as the start of treatment, not the whole of it.

Health Consequences

Hepatic

• Fatty liver (steatosis), often reversible with abstinence
• Alcoholic hepatitis
• Cirrhosis
• Hepatocellular carcinoma

Cardiovascular

• Hypertension
• Cardiomyopathy
• Atrial fibrillation ("holiday heart")
• Hemorrhagic stroke

Gastrointestinal

• Gastritis, esophagitis, reflux
• Mallory-Weiss tears, esophageal varices in cirrhosis
• Pancreatitis (acute and chronic)

Cancer

Alcohol is a Group 1 carcinogen. Increased risk includes oral cavity, pharyngeal, laryngeal, esophageal, liver, colorectal, and breast cancers. The risk is dose-dependent — there is no clear "safe" amount with respect to cancer.

Neurological

• Peripheral neuropathy
• Cerebellar degeneration
• Wernicke encephalopathy and Korsakoff syndrome (thiamine deficiency)
• Alcohol-related dementia

Psychiatric

• Depression — frequently both cause and consequence
• Anxiety, panic disorder
• Sleep disturbance
• Increased suicide risk
• Cognitive impairment

Reproductive and Fetal

Heavy use impairs fertility in all sexes and increases miscarriage risk. Prenatal alcohol exposure causes fetal alcohol spectrum disorders, with effects ranging from subtle learning issues to fetal alcohol syndrome. No amount of alcohol has been established as safe in pregnancy.

Social

Job loss, financial difficulty, relationship breakdown, legal problems (DUI, assault), and family disruption are routine downstream consequences. Children of parents with AUD have elevated rates of mental health and substance use problems themselves.

Causes and Risk Factors

Genetic

Heritability is approximately 50%. Specific genetic variants — for example, variants of ADH and ALDH genes — influence both metabolism and drinking patterns. A flush reaction common in some East Asian populations (associated with ALDH2 variants) lowers AUD risk. Family history is one of the strongest predictors.

Neurobiological

Repeated heavy use produces lasting changes in reward circuitry (dopaminergic systems), stress response (extended amygdala, CRF), and inhibitory control (prefrontal cortex). These changes shift the balance from "wanting" alcohol from a positive choice to a compulsion driven by craving and relief from negative states.

Psychological

• Trauma and adverse childhood experiences
• Untreated anxiety, depression, ADHD, PTSD
• Impulsivity and low distress tolerance
• Use of alcohol for coping rather than for pleasure

Social and Environmental

• Early age of first drink (before age 15)
• Family environment of heavy drinking
• Peer norms and culture
• Occupational environments with heavy drinking
• Easy access and low price
• Marketing exposure

Concurrent Psychiatric Conditions

Up to half of people with AUD have at least one other psychiatric condition. Effective treatment usually requires addressing both — treating AUD alone often leaves the underlying driver in place; treating only the comorbidity leaves the AUD intact.

Assessment and Diagnosis

Screening

Brief, validated screening tools are the standard of care in primary care and routine clinical encounters:

• AUDIT (Alcohol Use Disorders Identification Test): 10 items, gold standard
• AUDIT-C: 3-item shorter version
• CAGE: 4-item brief screen
• Single-Item Screening Question: "How many times in the past year have you had X or more drinks in a day?" (X = 5 for men, 4 for women)

Diagnostic Interview

The DSM-5 criteria are applied in a clinical interview that covers quantity, frequency, pattern, consequences, and tolerance and withdrawal symptoms over the prior 12 months.

Medical Evaluation

• Liver function tests (AST, ALT, GGT)
• Complete blood count (looking for macrocytic anemia)
• Comprehensive metabolic panel
• Hepatitis serologies
• Vitamin levels — thiamine, folate, B12
• EKG for older patients or heavy drinkers

Withdrawal Risk Assessment

The CIWA-Ar (Clinical Institute Withdrawal Assessment) is the standard scale for assessing withdrawal severity and guiding medication. A history of seizures or DTs significantly raises risk and typically warrants inpatient detox.

Differential Diagnosis

• Other substance use disorders (frequent co-use)
• Primary mood or anxiety disorder presenting with self-medication
• Adjustment disorder with alcohol use
• Bipolar disorder with substance use during mood episodes

Treatment Approaches

FDA-Approved Medications

Naltrexone

Available as a daily pill (50 mg) or monthly injection (Vivitrol). Naltrexone blocks the opioid receptors involved in alcohol's rewarding effects, reducing both craving and the pleasure of drinking. It does not require abstinence to start and is effective for both abstinence-oriented and reduction-oriented goals. Contraindicated with current opioid use.

Acamprosate

Acts on glutamate and GABA systems to reduce post-acute withdrawal symptoms — anxiety, sleep disturbance, low mood — that drive relapse. Best started after detox in abstinence-oriented treatment. Taken three times daily; renal function must be monitored.

Disulfiram

Causes an aversive reaction (flushing, nausea, palpitations) when alcohol is consumed, by blocking alcohol metabolism at the acetaldehyde step. Effective only when taken reliably, often as part of a supervised regimen. Contraindicated with significant cardiovascular disease.

Off-Label Medications With Evidence

• Topiramate
• Gabapentin (particularly useful for sleep and anxiety in early recovery)
• Baclofen
• Ondansetron (in early-onset AUD subtypes)

Behavioral Therapies

Cognitive Behavioral Therapy

CBT for AUD focuses on identifying triggers, building coping skills, restructuring beliefs that drive drinking, and developing relapse-prevention plans. Strong evidence base across populations.

Motivational Enhancement Therapy / Motivational Interviewing

Brief, structured approach to building intrinsic motivation for change. Particularly useful in early or ambivalent stages and as a first step before more intensive treatment.

Contingency Management

Tangible rewards for verified abstinence. Strong evidence in research contexts; logistics of implementation limit availability in many real-world settings.

Twelve-Step Facilitation

Structured therapy that promotes engagement with Alcoholics Anonymous or similar mutual-help groups. Outcomes comparable to CBT in head-to-head trials.

Community Reinforcement Approach (CRA) and CRAFT

Operant approaches that build a life around non-drinking reinforcers. CRAFT (Community Reinforcement and Family Training) is an evidence-based way for family members to help an unwilling loved one engage in treatment.

Mutual-Help Communities

• Alcoholics Anonymous (AA): Twelve-step program, free, widely available globally
• SMART Recovery: Secular, cognitive-behavioral self-help approach
• Refuge Recovery / Recovery Dharma: Buddhist-informed approach
• LifeRing, Women for Sobriety: Additional secular alternatives

Goal: Abstinence vs. Reduction

Abstinence is the goal for most severe AUD and for those with significant medical complications. For mild-to-moderate AUD, reduction can be a legitimate, evidence-supported goal, particularly when supported by naltrexone (the "Sinclair method"). Different goals require different treatment plans, and pretending otherwise often costs adherence.

Levels of Care

1. Outpatient — appropriate for many with mild-moderate AUD
2. Intensive outpatient (IOP)
3. Partial hospitalization (PHP)
4. Residential treatment (typically 28–90 days)
5. Inpatient detox for medically complex withdrawal

Recovery and Maintenance

What Recovery Looks Like

• Stable abstinence or controlled, low-risk use depending on goal
• Resolution of withdrawal and post-acute withdrawal symptoms
• Restored functioning at work, in relationships, in health
• Skills for managing cravings, triggers, and emotional states
• Identity and meaning grounded in something other than drinking

Realistic Trajectory

Recovery is rarely a straight line. Lapses are common and do not erase progress. The clinical task is to keep a lapse from becoming a full relapse — to re-engage promptly with the treatment plan. Outcomes improve with time: people in recovery for five years have very low relapse rates compared with those in their first year.

Post-Acute Withdrawal Syndrome (PAWS)

Many people experience anxiety, irritability, sleep disturbance, and mood instability for weeks to months after stopping. PAWS is real, expected, and treatable. Acamprosate, gabapentin, and patient sleep support all help.

Maintenance Strategies

• Continue medication if it is helping
• Engage with a mutual-help community that fits
• Treat co-occurring mood, anxiety, trauma, and ADHD
• Build sleep, exercise, and nutrition stability
• Develop relationships and activities that do not center on drinking
• Have a written relapse-prevention plan with early warning signs

Supporting a Loved One

What Helps

• Approach with concern and curiosity, not confrontation
• Focus on observable consequences, not character
• Learn about evidence-based treatment; do not assume rehab is the only option
• Consider CRAFT, which has the strongest evidence of any family approach
• Take care of your own mental health — Al-Anon or therapy

What to Avoid

• Threats and ultimatums you are not prepared to keep
• Covering for the consequences of their drinking
• Drinking heavily with them
• Believing that one conversation will produce change

When the Person Refuses Help

You cannot force readiness, but you can shift the environment in ways that make change more likely. CRAFT is a structured, evidence-based approach for family members of people who are not yet seeking treatment — and it has higher engagement rates than traditional interventions.